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PURPOSE; To evaluate the compara­
tive accuracy of magnetic resonance 
(MR) imaging relative to mammogra­
phy and ultrasonography (US) for 
assessing the extent of breast tumors.
MATERIALS A N D  METHODS: His­
tologic results and preoperative im­
aging findings (mammography, US, 
MR imaging) were analyzed regard­
ing tumor size and multifocality of 61 
tumors in 60 women undergoing 
mastectomy for carcinoma.
RESULTS: In 10% of cases, the index 
tumor was not seen at mammogra­
phy. With US, 15% of the index tu­
mors were not recognized, while MR 
imaging missed 2% of the index tu­
mors. On mammographic and US 
images, tumor size was underesti­
mated significantly (P < .005), by 14% 
and 18%, respectively, while MR im­
aging showed no significant differ­
ence in size compared with that 
found in a pathologic evaluation. 
Mammography showed 31% of the 
additional invasive lesions, while US 
showed 38% and MR imaging 
showed 100%.
CONCLUSION: MR imaging was the 
most accurate of the three preopera­
tive imaging modalities in assessing 
the size and number of malignant 
lesions in the breast.
Index terms; Breast neoplasms, MR, 00.121416, 
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At  present, the most effective imag- l ing technique for the detection 
of breast cancer is mammography,
Its sensitivity was close to 90% in a 
screening population (1). However, 
the extent of the tumor is often un ­
derestimated with this technique (2).
Ultrasonography (US) appears to be 
more accurate than mammography 
for determining actual tumor size, but 
results with respect to tumor detec­
tion remain disappointing (3).
In recent years, contrast material- 
enhanced magnetic resonance (MR) 
imaging has been added to the list of 
imaging techniques for breast lesions. 
Differentiation between benign and 
malignant lesions is still problematic 
in some cases; however, application 
of the dynamic turbo, fast low-angle 
shot (TurboFLASH; Siemens, Erlan­
gen, Germany) technique in the 
breast, which has recently been re­
ported, appears to be promising (4-6). 
With regard to the performance of 
MR imaging in size determination, 
few data are available (7,8). Accurate 
determination of the extent of a given 
tumor and possible multifocality is 
essential when a breast-conserving 
surgical approach is considered.
In the present study, a series of 60 
patients with malignant breast lesions 
were examined with mammography, 
US, and MR imaging. The findings 
from these three imaging methods 
were subsequently compared with 
histologic examinations. Special em­
phasis was placed on determination 
of the size and multifocality of the 
tumors.
MATERIALS AND METHODS
Histologic results and preoperative im ­
aging findings (mammography, US, and  
MR imaging) in 60 consecutive wom en  
undergoing mastectomy for carcinoma 
were analyzed. These wom en were sus­
pected of having breast cancer on the basis 
of clinical findings or conventional im ag­
ing studies— that is, mammography and
US. Various factors influence the decision  
to perform a mastectomy. Am ong these 
are the size of the tumor in relation to the 
size of the breast, a mammogram suggest­
ing multifocality or an extensive intra­
ductal com ponent, and the preference of 
the patient. The mean age of the patients 
was 53 (range, 32-72) years. Three wom en  
w ho had undergone a previous breast- 
conserving treatment were treated for re­
current cancer. O ne patient underwent 
bilateral mastectomy. A total of 61 mastec­
tomy specim ens were studied histologi­
cally.
For the mammographic examination a 
CGR 600T unit (GE Medical Medical Sys­
tems, Milwaukee, Wis) was used. In addi­
tion to the standard oblique and cranio- 
caudal projections, magnification views in 
both projections were obtained in most 
cases.
Whole-breast US was performed with 
an SSD 650 unit (Aloka, Tokyo, Japan) 
with a 10-MHz transducer, which allowed  
sufficient penetration of the breast in all 
patients. The results of physical examina­
tion and mammography were generally  
know n to the investigator. The US exami­
nation preceded MR imaging.
MR imaging w as performed with a 
M agnetom  63/84SP4000 imager (Siemens, 
Erlangen, Germany) at 1.5 T. Patients were 
studied in the prone position with a 
double breast coil. Gadopentetate dimeg- 
lum ine (Magnevist; Schering, Berlin, Ger­
many) at a dose of 0.2 mmol per kilogram  
of body w eight w as applied.
After sagittal localizer images were ob­
tained, a three-dimensional (3D) magneti­
zation-prepared rapid gradient echo (MP- 
RAGE) sequence w ithout use of contrast 
m edium  was performed (repetition time 
m sec/echo time m sec/inversion time 
msec = 10/4/300, 8° flip angle, 128 sec­
tions, effective section thickness of 1.4 mm, 
192 x 256 matrix, 300-mm field of view  
[FOV], transverse orientation, and an ac­
quisition time of 5 minutes). With multi- 
planar reconstruction, the optimal axial
A bbrev ia tions: DCIS -  ductal carcinoma in 
situ, FLASH = fast low-angle shot, FOV == field 
of view, IDC = invasive duct carcinom a, ILC = 
invasive lobu lar carcinom a, MP-RAGE =  m ag­
ne tiza tion -p repared  rapid g rad ien t echo, 3D =  
three-dim ensional.
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section plane was then selected through  
the center of the index tumor. This plane 
always included a cross section of the de­
scending aorta. In the same plane, 60 se­
quential breast images were obtained with 
a temporal resolution of 2.3 seconds dur­
ing 2 minutes, by using the dynamic Tur- 
boFLASH sequence (9/4/15, 8° flip angle, 
10-mm section thickness, 128 x  256 matrix, 
350-mm FOV, and two acquisitions). After 
the first four images were acquired, the 
contrast medium was administered intra­
venously within 10 seconds, follow ed by a 
bolus of 20 mL of normal saline solution. 
We recently reported a more detailed de­
scription of the dynamic TurboFLASH 
technique (6).
After the TurboFLASH sequence, the 3D 
MP-RAGE sequence was repeated w ith  
tuning parameters adjusted off line to 
match the precontrast parameter settings. 
The whole examination, including the 
precontrast MP-RAGE, the postcontrast 
dynamic TurboFLASH, and the postcon- 
trast MP-RAGE sequences, lasted about 20 
minutes. The data acquired with the Tur­
boFLASH sequence were then transferred 
to a separate console for subtraction of 
postcontrast from precontrast images,
The subtracted TurboFLASH images 
were used to determine the start and 
speed of enhancement, w hich were subse­
quently analyzed according to the follow ­
ing criterion: The image on which the d e­
scending aorta started to enhance was 
considered the reference image at time 
zero. Lesions that started to enhance 
within 11.5 seconds after aortic enhance­
ment were considered suspect for malig­
nancy (6).
From the subtracted MP-RAGE images, 
a 3D multiplanar reconstruction of the en­
tire breast was generated to evaluate the 
index lesion in more detail and to identify  
other possible foci of enhancement. The 
images were then evaluated according to 
the pattern and shape of enhancement. 
Focal enhancement, especially with ir­
regular borders, was considered suspi­
cious for malignancy (9). Diffuse field 
enhancement, either hom ogeneous or in- 
hom ogeneous, was considered equivocal, 
since this pattern of enhancem ent may be 
seen in both benign and malignant le­
sions. MR imaging is always performed 
before needle biopsy, so surgical changes 
pose no diagnostic problems.
All mastectomy specimens were exam­
ined with Egan's serial subgross and corre­
lated radiographic-histologic method (10). 
In this technique the surgical biopsy speci­
men and the whole-breast specim en are 
sectioned at 5-mm intervals in the trans­
verse direction and each section is radio­
graphed. Tissue blocks for histologic exami­
nation are taken from the radiologically 
suspicious lesions (ie, those with microcal­
cifications or architectural distortions) and 
from areas show ing grossly suspicious 
changes. In any breast specimen, an average 
of 25 tissue blocks are taken from the quad­
rant containing the index lesion, in addition 
to random samples from other quadrants, the 
nipple, and the central area beneath the 
.nipple-areolar complex. Both the pre­
cise site of the tissue blocks taken and the 
microscopically verified extension of each 
lesion are indicated on the specimen ra­
diograph (11). This method permits me­
ticulous histopathologic assessment of the 
extent and possible multifocality of the 
tumorous process. Enhancing lesions on 
MR images were identified and located on 
the specim en radiographs and then in the 
tissue sections, and the corresponding tis­
sue blocks were studied histologically.
The size of the tumor was assessed with  
all three im aging techniques by determin­
ing the longest axis of the tumor. The tu­
mor margins were defined by the area of 
microcalcification distribution, the extent 
of the soft-tissue component, and the area 
of architectural distortion of breast tissue.
At MR imaging the longest axis was as­
sessed by measuring the lesion on the sub­
tracted and reconstructed 3D MP-RAGE 
images. The size differences betw een im­
aging-based measurements and specimen- 
based pathologic measurements were ex­
pressed in relative terms. P  values for 
comparative performance in size determi­
nation were calculated.
RESULTS
Detection of the Index Tumor
A total of 61 tumors were evaluated. 
The imaging findings and definite histo­
logic results are summarized in Table 1. 
In six cases (10%) the index tumor was 
not visible on the mammograms.
With US, nine of 59 (15%) tumors 
were not recognized. In one case of 
DCIS and one case of IDC, US was
not performed.
All tumors but one were demon­
strated with the combined Turbo­
FLASH and 3D MP-RAGE MR imag­
ing technique. The single MR imaging- 
negative tumor was a DCIS with a 
diameter of 9 cm. Three lesions were 
not apparent in the chosen Turbo­
FLASH section, because the region of 
interest could not be properly identi­
fied on the precontrast 3D MP-RAGE 
images. However, all three were 
recognized on the postcontrast
3D MP-RAGE images. For the 40 cases 
of IDC, the m ean time to the start of 
enhancement on the TurboFLASH 
images was 6.2 seconds (range, 2.3- 
11.5 seconds); for the eight cases of ILC, 
the mean time was 7.9 seconds (range, 
4.6-11.5 seconds); and for the six cases of 
pure DCIS the mean time was 7,6 sec­
onds (range, 6,9-9.2 seconds).
Size Determination of the Index 
Tumor
The pathologically determined 
tumor size, based on the largest 
diam eter varied from 1 to 15 cm. 
Deviations in the size of the lesions 
determined with mammography, US, 
and MR imaging, respectively, com­
pared with those determined histo­
logically, are shown in Figures 1-3.
When sizes are expressed in rela­
tive terms, mammography and US 
underestimate the actual tumor size 
by statistically significant (P < .005) size 
differences of 14% and 18%, respec­
tively, in contrast to a not significant size 
difference of only 1 % for MR imaging 
(Table 2, Fig 4).
The discrepancies in size for mam­
mography, US, and MR imaging for 
the various tumor types (IDC, ILC, 
and DCIS) are listed in Table 3.
Detection of Invasive Tumor 
Multifocality
Of the 61 mastectomy specimens,
12 contained a multifocal invasive 
tumor at histologic examination, with, 
respectively, one (seven cases), two 
(two cases), and  multiple (three cases) 
small tumor foci in addition to the 
index tumor. One specimen con­
tained multicentric lesions at the site 
of the second invasive tumor, a dis­
tance of 4.5 cm from the index tumor 
(Fig 5). These findings are summa­
rized in Table 4. MR imaging was
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Figures 1-3. Deviations of (1) mammographically determined tumor 
sizes (n - 55), (2) US-determined sizes (n = 50), and (3) MR imaging- 
determined sizes (n = 60) from histologically determined sizes. (Some 
dots represent more than one tumor.) Increasing deviation of mammo­
graphie and US tumor sizes with increasing histologic tumor size is ap­
parent. The deviations are expressed in relative terms (Table 2), Mam­
mographie and US measurements significantly underestimated tumor size 
by 14% (relative deviation = 0,01) and 18% (relative deviation = 0.01), re­
spectively. in contrast, there was no significant difference (1%) between the 
MR imaging and histologic tumor sizes (relative deviation =  0.1).
2 4 6 8 10 12 14 16
histological diameter (cm)
3.
T able 2
Deviation in Tumor Size with Mammography, US, and MR Imaging Relative to 
Histologic Tumor Size
' M ammography ■ US . MR Im aging
Deviation (n -  55) (n ~ 50) (// ~  60)
Systematic —14%* , -18% * i% f
Random 41% 37% ■ 29%
* P < .005. 
t  Not significant.
100% accurate in identifying tumor 
multifocality, whereas mammography 
had an accuracy of 31% and US had 
an accuracy of 38%.
DISCUSSION
Accurate definition of the extent 
and possible multifocality of tumors is 
essential for making the choice be­
tween the therapeutic options of 
breast-conserving treatment and mas­
tectomy.
In the present study the results of 
mammography, US, and MR imaging 
were compared with the final histo­
logic results in 61 mastectomy speci­
mens for determining the actual size 
of the reference tumor as measured at 
histologic examination. Also, the accu­
racy in recognizing additional tumor 
foci—that is, tumor multifocality— 
was evaluated.
Detection of the Index Tumor
The reported sensitivity of mam­
mography for the detection of breast 
cancer varies between 69% and 90%. 
Peeters et al (12) reported a sensi­
tivity of 93% and a specificity of 99% 
for mammography in a breast screen­
ing study. Baker (1) reported a multi­
center study in which 90% of all m a­
lignant lesions were detected in a 
screening population. In a symptom­
atic patient population the sensitivity 
of mammography for malignancy 
varied from 81% to 96% (13). The 
sensitivity of 90% in the present 
study of 60 symptomatic patients is 
within this range.
The most important role of US is 
the differentiation between cystic and 
solid masses. While US is 96%-100% 
accurate in identifying a cyst, it is less 
reliable in differentiating between
benign and malignant solid masses, 
especially because of the overlap be­
tween the features of certain types of 
fibroadenomas and carcinomas (14).
In the present study, in nine of 59 p a ­
tients no abnormalities were seen 
with US in the mammographically 
suspicious area, resulting in a sensitiv­
ity of 85%. However, five of the nine 
US-occult tumors were DCIS. This 
result is in agreement with the experi­
ence of Kopans et al (15), indicating 
that pure DCIS is often not seen on 
US scans, and thus US is not suitable 
for screening purposes.
The sensitivity of MR imaging in 
various studies for detecting carci­
noma of the breast is high. Harms et 
al (16) reported a sensitivity of 100%, 
while Heywang-Kobmnner et al (17) 
claimed a sensitivity of 99.5%.
In a previous study in which the 
combined 3D MP-RAGE-Turbo- 
FLASH technique was used in 83 p a ­
tients, we achieved a sensitivity of 
95% and a specificity of 86% (6). The 
3D MP-RAGE sequence has a high 
sensitivity for detecting lesions, while 
the TurboFLASH sequence is able to 
help differentiate between benign 
and malignant lesions.
All but one of the index tumors in 
the present study were recognized at 
MR imaging and classified as malig­
n a n t The single tumor occult to MR 
imaging was a well-differentia ted 
(non-comedo) DCIS detected by means 
of mammo graphic microcalcifications.
On the whole, the most rapid start 
of enhancement was shown by the
Volume 197 • Number 3 Radiology • 745
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Figure 4. Images of a 65-year-old woman with suspicious microcalcifications in the left breast detected at routine screening, (a) Cephalocau­
dal and (b) oblique-lateral projection mammograms show microcalcifications in a 3.5-cm-diameter region (arrows). N o abnormality was seen in 
the right breast (c) Subtracted reconstructed 3D MP-RAGE image shows enhancement in a 7-cm-diameter area, Histologic examination re­
vealed an IDC with a 7-cm diameter.
Table 31 I
Deviation in Tumor Size with Mammography, US, and MR Imaging Relative to 
Histologic Tumor Size, by Tumor Type
Tumor Type
4 '
Mammography US MR Imaging
IDC ~5%* (37) -9 % *  (37) —3%* (41)
ILC -37%t (7) -43%t (8) —16%* (9)
DCIS —29%t{8) (2)* - 8%* (7)
Note.—Numbers in parentheses are number of tumors. 
* Not significant 
t P < .05.
$ N ot performed.
IDCs. The six cases of pure DCIS be­
gan enhancing an average of 1.4 sec­
onds la ter, while the eight cases of ILC 
began enhancing at a mean of 7.9 sec­
onds, or 1.7 seconds later than the IDCs.
Size Determination of the Index 
Tumor
Fomage et al (3) compared the clini­
cally, mammo graphically, and sono- 
graphically determined sizes of cancers 
in a series of 31 patients and concluded 
that mammography is less accurate than 
sonography in assessing tumor size.
Harms et al (5) reported that tumor 
size can be better assessed with MR 
*
imaging than with mammography 
and that MR imaging often provides 
better delineation of a lesion than 
does mammography. In a series of 47 
malignant lesions, tumor size mea­
sured with MR imaging correlated 
more closely with histologic measure­
ments than did mammographic mea­
surements in 33 cases (7). Gribbestad 
et al (18) also demonstrated that MR 
imaging showed better accuracy in 
tumor size determination than did 
mammography.
In the present study, MR imaging 
proved to be the most accurate 
method for assessment of tumor size 
(Figs 1-3, Table 2). Nevertheless, an 
extreme discrepancy was noted in the 
case of an ILC in which the patho­
logic tumor diameter was 15 cm, but 
only part of it—namely, 4 cm—en­
hanced. Also, a well-differentiated 
(non-comedo) type of DCIS with a 
diameter of 9 cm showed no enhance­
ment at all.
In a subset of eight patients, we also 
studied the capability of MR imaging
to show an extensive intraductal com­
ponent in association with the inva­
sive tumor (19). While the size of the 
invasive part was correctly estimated, 
the DCIS component, with an average 
extension of 3.5 cm (range, 1-7 cm), 
was underestimated by more than 1 
cm in all patients. In six of these eight 
patients the DCIS was histologically 
of the well-differentiated (non-com­
edo) type. This finding is in accor­
dance with the results of Greenstein 
Orel et al (20), who describe how 
some cases of DCIS may be impossible 
to identify with MR imaging. In con­
trast, Heywang-Kobrunner (21) de­
scribes a series of 19 DCIS tumors that 
apparently all enhanced.
Detection of Invasive Tumor 
Multifocality
Holland et al (2), in a study of 282 
invasive cancers, showed that in 43% 
of the tumors, additional tumor foci 
were present beyond 2 cm from the 
margin of the index tumor (2). The 
majority of these foci were occult at
mammography. These data indicate that 
while mammography is accurate in de­
tecting the reference lesion, it is less ac­
curate in identifying multifocality.
To our knowledge, no results on 
the ability of US in detecting breast 
tumor multifocality have been re­
ported. Harms et al (7) reported that 
MR imaging depicted all additional 
mammographically occult cancers in 
'11 of 30 cases in which the whole- 
breast specimen was serially sectioned 
(7). Heywang-Kobrunner and Oel- 
linger (22) reported that MR imaging 
was able to show 80% of all malignant 
foci, whereas mammography showed 
only 20%. In the present study, all histo­
logically proved additional malignant 
invasive lesions were identified on MR 
images (Table 4). All these foci were 
characterized by irregular edges on the 
3D MP-RAGE images. Two fibroadeno­
mas were correctly identified on 3D MP- 
RAGE images; however, three addi­
tional lesions that fulfilled our MR 
imaging criteria for malignancy turned 
out to be fibroadenoma,s.
The results of this study indicate 
that MR imaging can play a comple-
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F igure  5. Im ages of a 44-year-old w om an  
w ho  h ad  u n d e rg o n e  b reast-sav ing  th e rap y  2 
years p rev iously  for a n  IDC of the left breast 
and  w ho now  presented  with a palpable lum p 
in the lateral u p p e r  quadran t of the same breast, 
(a) M am m ogram  show s an irregular 1.5-cm- 
diam eter lesion (arrow), along w ith a surgical 
clip from the previous operation. US findings 
confirm ed the  p resen ce  of the  lesion, (b) Sub­
tracted  sagittally  reco n s tru c ted  MP-RAGE 
im age show s tw o  e n h a n c in g  lesions (arrows), 
one co rre sp o n d in g  to the index  tum or an d  
an  ad d itiona l 1-cm -diam eter lesion ju s t cau­
dal to the m am illa. H isto logic exam ination 
revealed  th a t bo th  lesions w ere  IDCs.
mentary role to mammography and 
US in guiding the surgical treatment 
of breast cancer, by its ability to pro-
T a b le  4
S e n s it iv i ty  o f th e  T h r e e  I m a g in g  M o d a li t ie s  fo r  D e te c t in g  In v a s iv e  T u m o r  
M u lt ifo c a li ty  a n d  U n if o c a l i ty
Type M am m ography US MR Imaging
Multifocality (n ~  13) 
Unifocality {n -  48)
31% (4) 
100% (48)
38% (5) 
100% (46)
100% (13) 
94% (47)
Note.—Numbers in parentheses are number of tumors.
vide a better assessment of the extent 
and multifocality of the malignant 
process. In this retrospective study, 
we analyzed 61 mastectomy speci­
mens. Multifocality was noted histo­
logically and with MR imaging in 13 
patients, whereas it was seen with 
mammography in only four cases. 
Since the choice between breast-sav­
ing therapy and mastectomy is not 
only based on preoperative imaging 
findings but also on the judgment of 
the surgeon and the wish of the pa­
tient, it is difficult to isolate the effect 
of MR diagnosis alone on patient 
treatment. Because false-positive di­
agnoses are rare in our experience, it 
can be concluded that MR imaging 
was decisive in a maximum of nine 
patients.
In conclusion, the histologic find­
ings of 61 mastectomy specimens 
were correlated with preoperative 
mammography, US/ and MR imaging 
results. MR imaging showed all histo­
logically proved malignant lesions 
except one and allowed estimation of 
the size of the tumor more accurately 
than did mammography or US. The 
size of larger tumors was especially 
underestimated with mammography 
and US. Additional malignant lesions, 
in particular invasive foci of multifo­
cal tumors, were best identified with 
MR imaging.
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